XML 50 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2018
Schedule of stock-based compensation
The following table summarizes stock-based compensation expense related to all of the Company’s stock awards included by operating expense categories, as follows:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2018
 
2017
 
2018
 
2017
Cost of revenues
$
1,300

 
$
471

 
$
2,412

 
$
2,208

Research and development
1,802

 
953

 
3,342

 
2,980

Selling, general and administrative
4,536

 
1,214

 
9,070

 
5,561

Total stock-based compensation expense
$
7,638

 
$
2,638

 
$
14,824

 
$
10,749



The following table summarizes stock-based compensation expense related to all of the Company’s stock awards included by award types, as follows:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2018
 
2017
 
2018
 
2017
Stock options
$
1,980

 
$
1,535

 
$
3,740

 
$
2,988

Restricted stock awards
5,658

 
1,036

 
11,084

 
7,431

Employee Stock Purchase Plan

 
67

 

 
330

Total stock-based compensation before taxes
$
7,638

 
$
2,638

 
$
14,824

 
$
10,749

Tax benefit
$
531

 
$
506

 
$
2,954

 
$
1,713


Stock options  
Schedule of fair value assumptions
The Company uses the Black-Scholes option pricing model for determining the estimated fair value for stock options. The weighted-average assumptions used in the Black-Scholes option pricing model are as follows: 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2018
 
2017
 
2018
 
2017
Expected stock price volatility
65.1
%
 
53.2
%
 
65.1
%
 
49.2
%
Risk-free interest rate
2.6
%
 
1.7
%
 
2.5
%
 
1.7
%
Expected life of options (in years)
4.08

 
4.05

 
4.08

 
4.03

Expected dividend yield
0.0
%
 
0.0
%
 
0.0
%
 
0.0
%
Weighted-average fair value (grant date) of the options
$
5.47

 
$
6.87

 
$
5.34

 
$
7.79

Schedule of information about stock options outstanding
The following table summarizes information about stock options outstanding as of June 30, 2018
Options
 
Number of
Options
 
Weighted-
Average
Exercise Price
 
Weighted-
Average
Remaining
Contractual
Term (Years)
 
Aggregate
Intrinsic
Value
Outstanding at December 31, 2017
 
3,950

 
$
21.54

 
 
 
 
Options Granted
 
902

 
10.37

 
 
 
 
Options Exercised
 

 

 
 
 
 
Options Cancelled
 
(290
)
 
24.40

 
 
 
 
Outstanding at June 30, 2018
 
4,562

 
$
19.15

 
5.37
 
$
566

Vested at June 30, 2018
 
1,420

 
$
30.97

 
3.46
 
$

Exercisable at June 30, 2018
 
1,420

 
$
30.97

 
3.46
 
$

Restricted stock awards  
Schedule of unvested restricted stock
A summary of the Company’s unvested restricted stock at June 30, 2018, and changes during the six months ended June 30, 2018, is presented below:
Unvested Restricted Stock
 
Number of
Awards
 
Weighted- Average
Grant Date
Fair Value
Unvested at December 31, 2017
 
2,064

 
$
22.75

Granted
 
1,329

 
10.17

Vested
 
(499
)
 
30.27

Forfeited
 
(109
)
 
19.56

Unvested at June 30, 2018
 
2,785

 
$
15.45